Literature DB >> 12482577

Activity of the A3 adenosine receptor gene promoter in transgenic mice: characterization of previously unidentified sites of expression.

Ron Yaar1, Edward D Lamperti, Paul A Toselli, Katya Ravid.   

Abstract

Sites of A3 adenosine receptor gene expression have not been fully explored nor has this gene's promoter activity been confirmed in vivo. Transgenic mice were generated in which 2.3 kb upstream of the transcriptional start site of the mouse A3 adenosine receptor was coupled to a beta-galactosidase reporter gene. Selective transgene expression was detected in testis and brain as well as at other sites in which A3 adenosine receptor message has not been previously reported, including retinal ganglion cells and smooth muscle cells of the cerebrospinal vasculature. Our study suggests that this promoter may be useful in the selective targeting of gene expression to specific tissues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12482577     DOI: 10.1016/s0014-5793(02)03612-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

Review 1.  Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.

Authors:  Kenneth A Jacobson; Athena M Klutz; Dilip K Tosh; Andrei A Ivanov; Delia Preti; Pier Giovanni Baraldi
Journal:  Handb Exp Pharmacol       Date:  2009

2.  Colocalization and regulated physical association of presynaptic serotonin transporters with A₃ adenosine receptors.

Authors:  Chong-Bin Zhu; Kathryn M Lindler; Nicholas G Campbell; James S Sutcliffe; William A Hewlett; Randy D Blakely
Journal:  Mol Pharmacol       Date:  2011-06-24       Impact factor: 4.436

3.  (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.

Authors:  Susanna Tchilibon; Bhalchandra V Joshi; Soo-Kyung Kim; Heng T Duong; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2005-03-24       Impact factor: 7.446

4.  The A2B adenosine receptor protects against inflammation and excessive vascular adhesion.

Authors:  Dan Yang; Ying Zhang; Hao G Nguyen; Milka Koupenova; Anil K Chauhan; Maria Makitalo; Matthew R Jones; Cynthia St Hilaire; David C Seldin; Paul Toselli; Edward Lamperti; Barbara M Schreiber; Haralambos Gavras; Denisa D Wagner; Katya Ravid
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

5.  Adenosine receptor expression in the adult zebrafish retina.

Authors:  Stephanie L Grillo; Dillon S McDevitt; Matthew G Voas; Amanda S Khan; Michael A Grillo; Salvatore L Stella
Journal:  Purinergic Signal       Date:  2019-07-04       Impact factor: 3.765

Review 6.  Mechanisms of induction of adenosine receptor genes and its functional significance.

Authors:  Cynthia St Hilaire; Shannon H Carroll; Hongjie Chen; Katya Ravid
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

7.  The P2X(7) receptor in retinal ganglion cells: A neuronal model of pressure-induced damage and protection by a shifting purinergic balance.

Authors:  Claire H Mitchell; Wennan Lu; Huiling Hu; Xiulan Zhang; David Reigada; Mei Zhang
Journal:  Purinergic Signal       Date:  2008-10-16       Impact factor: 3.765

8.  Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration.

Authors:  Irina M Fedorova; Marlene A Jacobson; Anthony Basile; Kenneth A Jacobson
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

9.  The P2X(7) receptor in retinal ganglion cells: A neuronal model of pressure-induced damage and protection by a shifting purinergic balance.

Authors:  Claire H Mitchell; Wennan Lu; Huiling Hu; Xiulan Zhang; David Reigada; Mei Zhang
Journal:  Purinergic Signal       Date:  2009-02-25       Impact factor: 3.765

10.  Treatment of chronic neuropathic pain: purine receptor modulation.

Authors:  Kenneth A Jacobson; Luigino Antonio Giancotti; Filomena Lauro; Fatma Mufti; Daniela Salvemini
Journal:  Pain       Date:  2020-07       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.